Menu
GeneBe

CKMT1B

creatine kinase, mitochondrial 1B

Basic information

Region (hg38): 15:43593053-43604901

Previous symbols: [ "CKMT", "CKMT1" ]

Links

ENSG00000237289NCBI:1159OMIM:123290HGNC:1995Uniprot:P12532AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CKMT1B gene.

  • Inborn genetic diseases (7 variants)
  • not provided (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CKMT1B gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
6
clinvar
1
clinvar
1
clinvar
8
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 6 1 1

Variants in CKMT1B

This is a list of pathogenic ClinVar variants found in the CKMT1B region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
15-43596261-G-T not specified Uncertain significance (Dec 03, 2021)2263893
15-43596282-C-T not specified Uncertain significance (Oct 26, 2022)2289474
15-43596460-C-T not specified Uncertain significance (Dec 09, 2023)3145262
15-43596479-A-G not specified Uncertain significance (Aug 09, 2021)2221965
15-43596485-G-A not specified Uncertain significance (Jun 16, 2023)2604172
15-43598908-G-A not specified Likely benign (Mar 23, 2022)2408870
15-43598921-T-G not specified Uncertain significance (Aug 12, 2021)2243008
15-43598936-G-A not specified Uncertain significance (Mar 12, 2024)3145260
15-43599181-G-A not specified Uncertain significance (Nov 18, 2022)2351987
15-43599215-G-A Benign (May 02, 2018)778548
15-43599239-G-A not specified Uncertain significance (Mar 01, 2024)3145261
15-43599671-CTCATAGCAGGTGGCCAAGGAAGCTGATAGTCAATACCAGGGACCAGGAAGGTCGTGACCAGTCCTGGAGGCCCCAGGCTGTACTTCGACCTATAATAGACAGGGAATGGGAGTAATATCACAACTCAGCTCTCCAGGAGCATTGATACTTGGAAATTAGCGCTCTGCCTGTAGACTCCTTCACTCCAGGGATCTCCCTGGGTGCACTCTAAGAGCCAGACAGCACCAAATTAGGGGTTTGATTCTGGGTCAGGAGATGGAGGATCAAGCTGTGCAGCTGGGAACTCACCTTGCTGTTCTGGGCTCTCCTTTCCCTCATGTTGGGCCCATGCAACTGCTCGTCGCTGCTCAGGACTCAGAAAGGCCATTTGCTCAGGAGTGACAGCCACAGCCTGAGCACTGGTGAGACTAGATAGTTGGATGGGACTAAACACCACCTGAGGGCAGGGGTAGGAATCAGTGCATGCATGTAGTCCCCATTGGGCCCTGGCTCTCCTGTGGTCACCCCAGTCCATTAATACTTACAGCAAATTTAGGAGGAGGGATGACAGAAATGGCAAGAGGAGTAACGCCCTGGATCTGTCCCCGCAGCAGTGCTGAAAGAGCCAGGTCTGGGATCCCAGCTGTTGAAGCAAGTGGCATCCAAACATTGTCTTAGACTGACCTTCCCTCTCTTCAAACCTATAGACCTTCTCTAACTACTCCCAAAGTGCCCTATCATAGACCTTCCCCAATATGTCTCTAGCCCCTTATTTAAACACCCTCAGGCCCCCACCTTAAGAATTGCAGGGCAGTCTTCCATCCAGTCCACCCATGGTATAGAAACCAAACCAACTTGCACCAGCAGTGGCCCAGCTCCCCACCTGCTATGGTGCCAATTTCAGTGAAGATCTCAGGCCCCCAGTTACTGATTGGGCCAAACCCACCAGGCAGTACAAGTAGGTGGGCCAGAACCTCCAGTTGTTCCTCAGAGCACTGGAGATGCAGGGTGCCGAGGAAGAGAGCTGCTTGGCTGTAGAACAGTAGGAAGGAAGGAAGAAGAATTCGGCTTCAGTGAAAGGGGCTGTGGTCATGAGACAAAGGAAGAGATGGCTTCAAATGAGTTCCCTTCCTCCATGGGACCAGACCTTCATGATCCTTCTTTCCCCAGTAAGTCCACCTTTACCTCAGCACCACCACCCTCAGCCCCTTCACAAATGACCTGAACTCCCAACTGCTGATGTGCTGGAGCTCCTCTGGCCGCAGTCCACAGAGAGTATAACCCAGCGCTGTCAGATGAACGAAGTCCAGGTGGCTCACATGCCGACCACTCTGCCGTAGGAAACTGGAGACCACAATGCGGAGCTGGGGTGGGGGGTGGGAGAAGAGGGGAAGGAGGAAAGTTATGGAGAATTAATGGACAGGGAAGTGATAGGTGTTACTGGGTTATATTCTGTTACTATTAAGACCTAAGGAGTCATGGGGAAGGCTGAGGACTCAGAAAAGAAAAGGAAAGAAAAAGAGGAAGCCTCCAGGAAAAGAGGTAGGAGACAGTATTATGTGTCCAGGGCCTCAGAGTGAATAAATCAGAGTCCTGAAGGTCACTAGTATGGGGTATCAACAAAAGATAGAAAGAAGGACCAGGTAGGGTCACAGGAAAAAAATTCCTTGGGCTTTAGATGATCTATAGGGCTGGGTCTGTGGGATGGGTGTTTGGGAAGCCGTAGGGAGGAGGAAAAGTGTTACCTGAGTGGTGCTCCAGCCATCTATCTGCCCCAGGGTGCTCAGCACTCCCCAGTCCACTAGGATCAGCTCCTGTAGTTCCCGATCTCCTAGACCTATTAAGAGCCTACCAAGCTGCAGGATCTGCTCAGGACGAAATCCCCGGGGGGGACCCCACAACTAGGAGAAAGACAGGAACAATGTGAGTGGAAAAGCAGTGGATTGGGAGTCATACTGCTGGGTTTTAAGTCTTGCCTCTGCCCTTAGCTGTATAACTCTAGGTAAATCATTTGCCTTTTCTTTAGTTTCCTCCACTATAAAATGAGACCGTTGCCTTACAGTTCCTCTAAGGTGTTTTGAAAGACATTACAATCAGTGGAAAAGAAGAGCAAACTAACTCTAGTCCATGAGTTCCACACTTTTATGTGCATCAGACACAGAGACGCTTATTAAAACAGATGCCTAGGGCCCAGCACAGTGGCTAACAGCTGTAATCCCAGCACTTTGGGAGGCTGAGGTGGGAGGATTGCTTGAGCCCAGAAGTTCGAGACCATCCTGGGCAACATAGTGAAACCCCATCTCTACCAAAGATACAAAAATTAGCCAGGTGTGGTGCACCTGTAGTCCCAGCTACTTGAGAGGCTGAGGCAGGAGGATCGTTTGAACCCAGGATGTAGAGGTTACAGTGAGCCAAGATCACACCACTGCACTCCAGCCTGGATGCTGGGTGACAGAGTGAGACTCTGTCTCAAAAAAAAAAAAAAAAAAAAAAAAAGGAGATGCAGATGTCTAGACTCTTTCCCCCAGAGGCTTATTTTTTAATTTATGAGACAGGGTCTTGCTCTGACACCCAGGCTGGAGGGCAGTGGTGCGATCTTGGCACATTGCACCCTCCACCTCCTGCACTCATGGGATTCTCCTACCCCAGCCTCCTGAGTAGCTGGGATTACAGGCATGTGCCGCCACACCCAGCTAATGTTTTTTCTATTTTTAGTAGAGACAGGGTTTCACCATGTTGCCCAGTCTGGTCTCTAACTCCTGGGCTCAAGCAATCCACCTGCCTCCGCCTCCCAAAGTGCTGTGATTACAGGCATGAGTCACTGCGCCCAGCCTCCCCAAAGGTTTTTATTAAGTCAGTGAAGCATGGTAATCTGGCACTGGCACTGTTCCCATGCTCAGTTCAGCAGCACATACCCCAAAAAATTGGAATGATACAGAGATTTGCATGGCGCCTGTGCAAGGATAACACGCAAATTCATGAAGCATGCCTTTTTTTTTTTTTTTTTTTTTTGAGATGGAGTCTTGCTCTGTCACCCAGGATGGAGTGCATTGGCTTGACTTCGGCTCACTGCAAGCTCCCCCTCCCAGGTTCACGCCATTCTCCTGCCTCAGCCTCCCAAGTAGCTGGGACAACAAGTGTGCACCACCATGCCCGGCTAACTTTTTTGTATTTTTAGTAGAGACCGTGTTTCGCCGTGTTAGACAGGATGGTCTTGATCTCCTGACCTCGTGATCTGCCCGCCTTGGCCTCCCAAAGTTCTGAGATTATAGGCGTGAGCCGCTGCACCCAGCCGAAGCATGCCATTATTTTTTTAAGAAAGAAAAAAAAATAAAGAAAAAAATCTGTTCCCTTGATGATCGTGATATGCATTAAAATTTGGTAACCACTGCTTTCGTCCCTCTATTCATTATACTAGCTCTCTTTCCTCAATATTTATCTCCCTTCACCTCCTACTTGTGACCCAAATCTTCTAACTCTTCTATCTCTTGCTTCCCCCACCTCTCATCCAACTCTCCATTCTCTTTGTGTCCTACATCACACCCAAATAGCTTCCTCATGGCCAACCCCAGTTGGCTCTCCATCCCTAACCTGTTTTGCTTTGCCCATGGCTGCCCGCAGTTCCTCAGGCCCAAGTCCTGGGTCTCCTGCAAATAATGTCAGGCAGTCCTCAAAGTCTGAGAGCTCCATCTCTGCAATCTGGGTTGCAGACCAGGCTGCTGGGAATGTCCCTCGTACATCTGCACAATTTGGCACAGGTTCTGAAGGGGGAAGGCAGGGCCAGGAGGTCAGCGCAGTAATAAAATATGCCCAGAGAGATATCTGTAGATAGAGTGAGTCTTCCAACCTTTGGAGGATAGAGCACTGTGAGAAATAGGGATCAAAGGAGTATTACAGAGTAATATGTATAGGGCTTAGGAGATAATAGAACAAGAAGTGATTGGAGATGCCAAGACTTTTATAGATGGAAGACTGAGGATGTTATTCAGAGATTTAATGGTAGCACTGAATTTGAACCCAGTTCTCCAGCCTCACAATGTCTCCTTCAAAGCTTCTAGGGATCTCCCCAGCAGAGAGCTCCACACTTAGCCGAGCTAGAGCTGAGTCTAGAGCAGACACGAGAGAGCAGGAAAATGGAAGTTCTGGGCTAAAAGAAAACTTAATAGTTTACAAACTCCCAGAACTACAGAATTCTAGAACTACAAGAGGCTTGAAGATCATCCCTCTAAACTCTTTGCTTTATAAATTAGAAAACCCAGTCCCAGGGAAGAGCACATGTAGAACCCAGACCGTTTGATACTCCCTGTACATCCTGCTGGACATATAAGTATTTGGGTAGTTTCACCTGGAAGATCCTCAGCAGCTGGTCGCACCACCCCTGCTACCAGGGCTGCTTTCTTGGCAGCAAGCTGTGGCTCCCTACACAGCTGTCCAACTCTGCTCTGCTCCCAGCTCTGCTGCTTTTCTAGAAGCCGCTCCAGGGTCTCTGGACCCAAGGCCTCCTGCATGAGAAGGTAGAAGGAGAGTGGGGAGATCTGGACAGATCAGGACCTGCTGCTATAGCTCTAAGTCCAAAGTCCTGTCTCTGTTTTGCAGTCTCCCCCCAGATCTAGGCTTCATATCCTTTGCCCTCTTTGGCCACGGGTCCCCATAACCAGCTCACCAGTCCCCTCTATGCATTTACTCCCTTCCCTTCTTCCTTCATCTCACCCTGGGGATCAAGGAAATTGCCTCAGTAGACAGAGTGAATACTAGGCGTCCAGCTTGCTCTACTTCATCCTGGCTCCACAACTCTGGTTTCCTGGGGACAGGAAGAAAATCGGGGGCTGGGGAGCTGAGGGAACTGTGAGGAAAAGGAAGGGGAAAAGAGGACATGCTAGGATTTCGGACACAGGGCTCCAGGGGACCTTAAGAATATGGAACAGGCTGCCACTGATGATGGTGGCTGAGGGACTGGGTATAGAATGAGTTAGAATCTGAAGTTCTCGAAGGTCCATACCCAAGAACAGACTCCTGCAATAGCAGCCATCCCAGCTCTGTGGCAAATGTCTCTCCTAGGCAGAAGCCTTGCAGCTGACTGAGATGGGACAGCAGGATCTGTAGGGGGATCTGTCGTGTGCTCTCTGTCCCCAGGAATCCAACCAAAGGGCCTAAGGTCTCCAGCACTTCCCCTGAGACTGGAGTCTCCTTTGGAGCCTGGAGAAGAGCATCAGAACTTGGACAATGCACTTCTGACTCAGAATACCAGACACCTTGATCAAGACACCAAGCCCCCTAACCTTCCCTCCCTCCTGCTCCCAGCTCAGCACCCTATGATGCTCACTACCTTTGTTCACTTCCTTAAGCAATGAGCCCAGATAGGAGCAGGCAGAAAGACTGAGAGGTGGACTCCAAGAGATTTCTCGGACTCCAAGAGGTATGGACAAGTAACGTGAAGCATATTATCAAGGAACAGAACCCAGAGGCAAAACAGGGGCCAGGCCTTGTAGACAGGAATCTGTTTGGCAGCAAGAAAGCAAGAAGTAGAGGGTTGGGGGACAGTCAGAGAGCATTGTCTGAGGAGCAAGAATTGCCCAGGGCAGCAAATCTGAGTCTGGTAGGGTGGACTCTTACCAGGTTTTGTAGTGCCCTCTCTGCCAGGGCTGCCTGGTGGAGGGGGGTCAGTGCCAGCAGCTGCTCTGGAGCTCTTTGCACCAGCTCCACCACCAACATAATGGATTCATTGGATAGTCTGTCCATCAACTGGATCCTATTACAGCAATTTGACAACAACAGGATTCAGGTGGAGCTGGGCCAAGTCGAGAAGGGACCACAAAACCCCACAGTCCGCAGCTAAGATGTGACCCCAGACCAAATTTAGTGAAGCTGGACAGGAACTGATAGTAAACAGCTCCAGGGCCAATTCCCACCATCAAGCTTGAGTGGGGGAGAAAAAGGGAGCAACATATTTCTAGTCTTCCTAAAAAAAAAAAATAACGAACAATCCTACCTGATCTAATGGACTCAAAAGCTCCAAATATTAAGTACCATTAACATTTCCCCATTTTATAGATTAAAAAACTGAGGTTCACAGAGATCAAATGTTGAGGTCTCTCACTCCCAATTCCCGTTTTTTTCCACAGGACCACCCTTCCTCTGCTTGTGAAGAGGTCCCTTCTTGTTTGTACGTGCTATACAATTTACAAAGTTCTTTCAGGTGTTATCTCATTTGATCCTACAACAAGACCTGGCCTCACTCCATCACTCAGGCTGGAGCACAGTGGTGCTGCGATCTCAGTTCACTGCAACCCGCACCTCCCAGGTTCAAGCAATTCTCGTGCCTCAGCCTCCCGAATAGCTGGAATTACACGCACGTGCCACCACGCCCAGCTAACTTTTGTATTTTTAGTAGAGATGGTGTTTTGCCATGTTGGCCAGTCTGGTCTTGAACACCTGACCTCCGTGATCCACCCACCTTGGCCTCCCCAAATGCTGGGATTATAGGCATGAGCCACTGCACCCAGACAAAATAGGTGTTTCTCTTATCCTTCTTTCACAAATGAGAAACTCAAGTTTTTTGATGCATGGTCTAGGATCTTTCACCTCATCTGTAACCTTGGGATTCTAAATTATCTCACAGAACCCACATATTTAAACAGATCTGAATGGCATTAAAAAAAAGTAAAAACAGGCCGGACGCAGTGGCTCATGCCTGTAATCCCAGCACTTTGGGAGGCCGAGGCAGGCAGATCACAGGGTCAGAAATTCGAGACCACCCTGAGCAACATGGTGAAACCCCGTCTCTACTAAAAATGCAAAAATTAGCCGGGTGTGGTGGCACGCGCCTGTAATCCCAGCTACTCAGCAGGCTGAGGCAGGAGAATTGCTTGAACCCCAGAGGGAGAGGTTGCAGTGAGCCGAGATGGCACCATTGCACTCCAGCCTGGGTGACAGAGCGAGACTCTGTCTCAAAAATATAAATAAATAAACAAATAAATAAATAAATCCCTTTTACCCGAAATCAGAGGTGATAACCTGTACCCTACCTAGGATTACCAGTTCTGGAACTGGGCTAAGTCATACAAGAGCTGAAATCTGTGGAAAGGCCTATAAAAATATAAGAATGTTGGGAAGCCGAGGTGGGCAGATCACTTGAAGCCAGGAGTTCAAGACCAGCCTGGCCAACATGGTGAAAGCTCGTCCCTACAACAAATACAAAAATTAGCCTGGCATGGTGGTGCACACCTACAGTCCCAGCTACTCGGGAGACTGAGGCAGGAGAATTGCTTGAACCTGGAAGATGGAGGTTGCAGTGAGCCGAGATCACGTCACTGCACTCCAGCCTTGGTGACACAGCAAAACTCTGTCTCAAAAAAAAAAAAAAAGAAAAAAAAGAAAAAAGTAGGAATGAAGTCAACTGCTTTTACTCCACTTCAGCTCCATATTCCCCAGGAAGACTGTAACACCAGCATTTTCCTATCCTGACTTACAGTGCGGATGGCAACGGGGTGGTGGTAGGGGTAAAATGAGAAAAGCAGCATATGAGTAACATACTAATAAATTTCTCCATGGGTAGGGAGGAGCCTTGGGTTCCTATAGCCTTTTCTTCCCACAACCTGTATATGAACGTGCTCTACAACATTCCTGCCATGGGGCCATCTGGCTTAGGCTCGAACAGCTCCAAGGACCAGGAACTCACTACCTTAGTTTTTCTTATACTATGTAAAAATCTGATCTCCGTTAACTACTCTTAGTCTTGCCCAATGGGGCCACTCATAAATATGACAATCTAATTTCTACTTGATAGCCCCTCAGGTATTTGAAGGTATTTATCACATTTTTCATATATTTTTCTCTCGATCTACTCCTCTGAATGCACTAAGAACACAGTGCCCTGAGCAAACTACAATCCTCTGGGGCAGATTTGGAGCATTGCCTCCCTCACTTCAGATGCTCTGTCTCAATCTCAATTAATGTGGACTAGGTTATTGTAAGATTACTTGGCAGGCTTCAATACAGTGTTGCCACCCTCAGCTGCCCTGTGCTGGAGCATATTCTGGGAACCAGTCAATACATAGAGCAACTTTGAATAAAATCCTCTGCTTTGGGCTATAAATTATGTCAGGGAACTACCAGACAGAAAAACTACCTCCTCCAGGGCATTCCCTAAGGGCAGATCTTCACCCCAGATTGAGCTTTCTGAGGGGCCAATATCTCTAGCTGCAGTACTTACGGTAAGTCCAGGAGTAGCTTGCTATCCAGCCCGTTCAGTTCTGGCCCTACAGTTGTCCATTCTGGTTCTGGCATTGCCATCCTCCGCTGTAGCTCTGCCCAGATACAGGCCCTCTGTAGGGAAGCAGTGTGAGGCCAGAGCAGAACATAGGAGCTGGGTTCTATACCTAGGGTCCCAGCCTCCCTGCTCCCACTAAAGTCCAGGCACCCCCTCTCACCAGGCTCCCTCGAACTCTAGTGGGCAGCTGATAGATCATGTGCACCACTTCAAGGAAGTCTACCATGGAGTTGATCTGCTGCAGAAACTCACAGGACATGCCTCCTGCCAGGGTGCCCAGAGCCCTGTGGGTGTGTGAGTGGGGAGAGGCTCATTCAACACATACAACAGCCTGTTTGCTCCTTGATATCAGTACTCTCAACACAAGTACAGATGTTCATCCACCGTAATTTATGGTTTGAGAAATGTTTTTACATAGATATCTCATCAGCTCCCCATAACATCACTGCTGTTTATCAGAGGAGAAAATAAGGATTTATGGAAGTCAGGTGACATTCCCAACATCATTCTGCTAGAAATGTGGTAAACTGAAACTAGAGCCATGTCTTAGATTCTGAAGCCCTTGGGAGGCTGAGGCGGGTGGATCACCTGAGGTCAGGAGTTTGAGACCAGCCTGGCCAAAATGGTGAAACCCCATCTCTACTAAAAATACAAAAATTAGCTGGGTATGGTGGCACATTCCTGTAATCCCAGCTACTCCAGAGGCTGAGACAGGAGAATCGCTTGAACCTGGGAGGCAGAGGTTGCAGTGAGCCGAAATCGCGCCACTGCACTCCAGCCTGGGCAACAGAGCAAGACTGTCTCGAAAAAAAAAAAAAAAAAAAGATTCTGAAGCCCATTGTTCTTCTAATGTGGGTGTAAGTAAAGTGATACCTTCTTATTCCTATTTATTCTTGCTTGGCCAGTGCCTCTGAAGTCATCCTGAAGTAAACTAACAGTAGCAAATGACTACTGGGACTTTACAATGGACCAAACACTGTGTTAAATATCTTACATGACCTACCTCATTTAATCTTCACAGTAACTACCTATGAGGCTGGTGCCATTGTAATTCTCATTTAAAGAAGGGAAAACTGACACAGGGACGTTAAATGACTTGCCCAAGAGGACAAGTAGGTGACAGGACTGGAACCTGAATCCAGGTTTTCTGAGTCCTTTGGCTCTAGTCAGGATAGGCATGGCACTGTGGAAGGAAAGGAGGGCAAAGGGAGGTGCTAGGAGAACGTCCACGAGGCAGGGACTATGCATCATTCATCCCTATATCCCCCATTCCATATCACATGGTGCCTGGCACATAGTAAGCACTCAAAAAAATGTTGGTCGAATTCAGCGCACTGCTCAACACAAGTTACTCACT-C Autosomal recessive nonsyndromic hearing loss 16 Likely pathogenic (Jul 01, 2021)1185095
15-43599999-A-G not specified • Autosomal recessive nonsyndromic hearing loss 16 Benign/Likely benign (May 01, 2023)505196
15-43600011-G-A Rare genetic deafness • Autosomal recessive nonsyndromic hearing loss 16 Pathogenic/Likely pathogenic (Sep 16, 2023)165298
15-43600020-C-G not specified Likely benign (Nov 24, 2015)178529
15-43600047-G-A Inborn genetic diseases Uncertain significance (Jun 09, 2022)2360670
15-43600069-AC-CT not specified Uncertain significance (Apr 25, 2017)505743
15-43600074-T-C Rare genetic deafness • STRC-related disorder Conflicting classifications of pathogenicity (May 05, 2023)505381
15-43600197-G-A Inborn genetic diseases Uncertain significance (Nov 30, 2021)2262982
15-43600240-C-T Inborn genetic diseases Uncertain significance (Nov 22, 2021)2396400
15-43600547-A-C Uncertain significance (Feb 16, 2023)2578088
15-43600571-C-G Inborn genetic diseases Uncertain significance (Dec 01, 2023)3171614
15-43600608-A-C not specified Uncertain significance (Oct 06, 2013)165300
15-43600609-G-A Autosomal recessive nonsyndromic hearing loss 16 • STRC-related disorder Conflicting classifications of pathogenicity (Jan 01, 2024)417924
15-43600609-GT-AG not specified • Autosomal recessive nonsyndromic hearing loss 16 • Inborn genetic diseases Conflicting classifications of pathogenicity (Aug 24, 2023)165301

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CKMT1Bprotein_codingprotein_codingENST00000300283 911848
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.00003230.5881256982321257320.000135
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.534961120.8580.000006672672
Missense in Polyphen4452.9870.83041183
Synonymous0.5883337.60.8780.00000182883
Loss of Function0.740810.60.7556.57e-7225

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002390.000235
Ashkenazi Jewish0.0008930.000893
East Asian0.00005640.0000544
Finnish0.000.00
European (Non-Finnish)0.0001410.000132
Middle Eastern0.00005640.0000544
South Asian0.000.00
Other0.0004900.000489

dbNSFP

Source: dbNSFP

Function
FUNCTION: Reversibly catalyzes the transfer of phosphate between ATP and various phosphogens (e.g. creatine phosphate). Creatine kinase isoenzymes play a central role in energy transduction in tissues with large, fluctuating energy demands, such as skeletal muscle, heart, brain and spermatozoa.;
Pathway
Arginine and proline metabolism - Homo sapiens (human);creatine-phosphate biosynthesis;Metabolism of polyamines;Metabolism of amino acids and derivatives;Metabolism;Arginine Proline metabolism;Glycine, serine, alanine and threonine metabolism;Creatine metabolism (Consensus)

Recessive Scores

pRec
0.665

Haploinsufficiency Scores

pHI
0.0983
hipred
N
hipred_score
0.341
ghis
0.540

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.965

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ckmt1
Phenotype
growth/size/body region phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);